The Medicines Company (MDCO)'s Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patient Outcomes Following PCI
11/16/2009 11:12:39 AM
More...
|
The Medicines Company (MDCO)'s Cleviprex Results Reported From Study in Patients With Intracerebral Hemorrhage
11/13/2009 9:59:00 AM
More...
|
The Medicines Company (MDCO) Announces Positive CHMP Opinion for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
10/23/2009 8:25:29 AM
More...
|
The Medicines Company (MDCO) Announces Option Grants Under NASDAQ Marketplace Rule 5635
10/16/2009 9:13:11 AM
More...
|
The Medicines Company (MDCO) Files Patent Infringement Lawsuits Against Teva Parenteral Medicines, Inc. (TEVA) And APP Pharmaceuticals
10/9/2009 8:27:29 AM
More...
|
The Medicines Company (MDCO) Announces Second New Patent Issuance for Angiomax(R)
10/8/2009 10:10:36 AM
More...
|
The Medicines Company (MDCO) Announces Preliminary Third Quarter 2009 Top Line Results
10/6/2009 10:51:49 AM
More...
|
The Medicines Company (MDCO) (JOBS) President, COO John Kelley Resigns
10/2/2009 8:07:45 AM
More...
|
The Medicines Company (MDCO) Announces Option Grants Under NASDAQ Marketplace Rule 5635
10/1/2009 11:57:26 AM
More...
|
The Medicines Company (MDCO) Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise and Potential Near Term Revenue Opportunity
9/30/2009 10:36:15 AM
More...
|
|